bromocriptine and fulvestrant
bromocriptine has been researched along with fulvestrant in 7 studies
Research
Studies (7)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Abu Khalaf, R; Abu Sheikha, G; Bustanji, Y; Taha, MO | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Arita, J; Ishida, M; Izawa, M; Mitsui, T | 1 |
| Freudenberg, JM; Fullenkamp, AN; Ho, SM; Medvedovic, M; Szeto, CY; Tam, NN | 1 |
| Bai, J; Gui, S; Zhang, Y | 1 |
| Bai, J; Lan, X; Li, C; Li, Z; Liu, Q; Wu, Y; Yu, G; Zhang, Y; Zong, X | 1 |
| Li, Z; Liu, Z; Shao, Z; Song, C; Wang, X; Xiao, Z; Yang, X; Zhang, K | 1 |
Reviews
1 review(s) available for bromocriptine and fulvestrant
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
Other Studies
6 other study(ies) available for bromocriptine and fulvestrant
| Article | Year |
|---|---|
Discovery of new cholesteryl ester transfer protein inhibitors via ligand-based pharmacophore modeling and QSAR analysis followed by synthetic exploration.
Topics: Cholesterol Ester Transfer Proteins; Drug Discovery; Hydrogen Bonding; Ligands; Models, Molecular; Molecular Structure; Quantitative Structure-Activity Relationship; ROC Curve | 2010 |
Absence of ligand-independent transcriptional activation of the estrogen receptor via the estrogen response element in pituitary lactotrophs in primary culture.
Topics: Adenoviridae; Animals; Bromocriptine; Butadienes; Cell Line, Tumor; Cells, Cultured; Colforsin; Epidermal Growth Factor; Estradiol; Estrogen Antagonists; Female; Fulvestrant; Genes, Reporter; Insulin-Like Growth Factor I; Integrases; Isoquinolines; Lactotrophs; Ligands; Luciferases; Nitriles; Pituitary Gland, Anterior; Prolactin; Promoter Regions, Genetic; Protein Kinase Inhibitors; Rats; Rats, Wistar; Receptors, Estrogen; Response Elements; Sulfonamides; Thymidine Kinase; Transcriptional Activation; Transduction, Genetic | 2010 |
Research resource: estrogen-driven prolactin-mediated gene-expression networks in hormone-induced prostatic intraepithelial neoplasia.
Topics: Animals; Bromocriptine; Calgranulin B; Cell Proliferation; Chemokine CXCL13; Epithelial Cells; Estradiol; Fulvestrant; Gene Expression Regulation, Neoplastic; Gene Regulatory Networks; Interleukin-1beta; Male; Prolactin; Prostate; Prostatic Intraepithelial Neoplasia; Prostatic Neoplasms; Rats; Reproducibility of Results; Reverse Transcriptase Polymerase Chain Reaction; Testosterone | 2010 |
Suppression of MMQ cells by fulvestrant: possible mechanism of action and potential application for bromocriptine-resistant prolactinomas.
Topics: Adult; Animals; beta Catenin; Bromocriptine; Cell Line; Estradiol; Estrogen Antagonists; Estrogen Receptor alpha; Female; Fulvestrant; Hormone Antagonists; Humans; Male; Middle Aged; Pituitary Neoplasms; Prolactinoma; Rats; Young Adult | 2013 |
The role of TGF-β/Smad signaling in dopamine agonist-resistant prolactinomas.
Topics: Adult; Animals; Antineoplastic Agents; Bromocriptine; Cell Line, Tumor; Dopamine Agonists; Drug Resistance, Neoplasm; Estradiol; Female; Fulvestrant; Humans; Male; Middle Aged; Phosphorylation; Pituitary Neoplasms; Prolactinoma; Protein Processing, Post-Translational; Rats; Signal Transduction; Smad3 Protein; Transforming Growth Factor beta1; Young Adult | 2015 |
Estrogen receptor α/prolactin receptor bilateral crosstalk promotes bromocriptine resistance in prolactinomas.
Topics: Adolescent; Adult; Animals; Antineoplastic Combined Chemotherapy Protocols; Bromocriptine; Cell Line, Tumor; Cyclin D1; Drug Resistance, Neoplasm; Estradiol; Estrogen Receptor alpha; Female; Fulvestrant; Humans; Hypophysectomy; Male; MAP Kinase Signaling System; Middle Aged; Neoplasm Recurrence, Local; Pituitary Gland; Pituitary Neoplasms; Prolactin; Prolactinoma; Rats; Receptors, Prolactin; Young Adult | 2020 |